Back to search
FDAFDA · Food and drugs·Recall number D-1303-2020

Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, 100 count bottles, Rx Only Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326 NDC 60505-0260-1

Published June 24, 2020 · Recall initiated: May 27, 2020

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above acceptable intake levels

What to do

Voluntary: Firm initiated · Press Release

Recall details

Manufacturer
Apotex Inc.
Distributor
Nationwide.
Lot
All lots remaining within expiry
Risk classification
Class II
Area (FDA)
drug
Country
Canada

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card